March 2 (Reuters) - MyMD Pharmaceuticals Inc MYMD.O :
* MYMD ANNOUNCES U.S. DRUG ENFORCEMENT ADMINISTRATION (DEA)
DETERMINES SUPERA-CBD™ IS NOT A CONTROLLED SUBSTANCE OR LISTED
CHEMICAL
* SCIENTIFIC REVIEW OF CHEMICAL STRUCTURE OF SUPERA-CBD WAS
CONDUCTED IN ACCORDANCE WITH CONTROLLED SUBSTANCES ACT &
GOVERNING REGULATIONS
* DEA SCIENTIFIC REVIEW CONCLUDES SUPERA-CBD WILL NOT BE
CLASSIFIED AS A REGULATED CHEMICAL OR REQUIRE SCHEDULING DURING
DEVELOPMENT
Source text for Eikon: ID:nBw3bcsYSa
Further company coverage: MYMD.O